These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
191 related items for PubMed ID: 7870083
1. Absence of Ki-ras mutations in exocrine pancreatic tumors from male rats chronically exposed to gabapentin. Fowler ML, Sigler RE, de la Iglesia FA, Reddy JK, Lalwani ND. Mutat Res; 1995 Mar; 327(1-2):151-60. PubMed ID: 7870083 [Abstract] [Full Text] [Related]
2. Activation of c-K-ras is frequent in pancreatic carcinomas of Syrian hamsters, but is absent in pancreatic tumors of rats. van Kranen HJ, Vermeulen E, Schoren L, Bax J, Woutersen RA, van Iersel P, van Kreijl CF, Scherer E. Carcinogenesis; 1991 Aug; 12(8):1477-82. PubMed ID: 1860169 [Abstract] [Full Text] [Related]
6. Activation of the c-Ki-ras oncogene in aflatoxin B1-induced hepatocellular carcinoma and adenoma in the rat: detection by denaturing gradient gel electrophoresis. Soman NR, Wogan GN. Proc Natl Acad Sci U S A; 1993 Mar 01; 90(5):2045-9. PubMed ID: 8446626 [Abstract] [Full Text] [Related]
7. Frequent activation of the Ki-ras oncogene at codon 12 in N-methyl-N-nitrosourea-induced rat prostate adenocarcinomas and neurogenic sarcomas. Sukumar S, Armstrong B, Bruyntjes JP, Leav I, Bosland MC. Mol Carcinog; 1991 Mar 01; 4(5):362-8. PubMed ID: 1680340 [Abstract] [Full Text] [Related]
8. Only wild-type c-Ki-ras codons 12, 13, and 61 in human pancreatic acinar cell carcinomas. Terhune PG, Heffess CS, Longnecker DS. Mol Carcinog; 1994 Jun 01; 10(2):110-4. PubMed ID: 8031464 [Abstract] [Full Text] [Related]
9. Specific Ki-ras codon 61 mutations may determine the development of urethan-induced mouse lung adenomas or adenocarcinomas. Nuzum EO, Malkinson AM, Beer DG. Mol Carcinog; 1990 Jun 01; 3(5):287-95. PubMed ID: 2244961 [Abstract] [Full Text] [Related]
10. [Point mutation at codon 12 of c-Ki-ras oncogene in human pancreatic neoplasms and normal human pancreas tissue]. Cui Q, Wang Z, Chen J. Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1994 Jun 01; 16(3):201-5. PubMed ID: 7805165 [Abstract] [Full Text] [Related]
11. K-ras oncogene activation in adenocarcinoma of the human pancreas. A study of 82 carcinomas using a combination of mutant-enriched polymerase chain reaction analysis and allele-specific oligonucleotide hybridization. Hruban RH, van Mansfeld AD, Offerhaus GJ, van Weering DH, Allison DC, Goodman SN, Kensler TW, Bose KK, Cameron JL, Bos JL. Am J Pathol; 1993 Aug 01; 143(2):545-54. PubMed ID: 8342602 [Abstract] [Full Text] [Related]
12. Frequent mutations of Ki-ras but no mutations of Ha-ras and p53 in lung lesions induced by N-nitrosobis(2-hydroxypropyl)amine in rats. Kitada H, Tsutsumi M, Tsujiuchi T, Takahama M, Fukuda T, Narita N, Konsihi Y. Mol Carcinog; 1996 Apr 01; 15(4):276-83. PubMed ID: 8634086 [Abstract] [Full Text] [Related]
13. Ki-ras and p53 mutations in pancreatic ductal adenocarcinoma. Rall CJ, Yan YX, Graeme-Cook F, Beauchamp R, Yandell DW, Povoski SP, Rustgi AK. Pancreas; 1996 Jan 01; 12(1):10-7. PubMed ID: 8927612 [Abstract] [Full Text] [Related]
14. Frequency and types of point mutation at the 12th codon of the c-Ki-ras gene found in pancreatic cancers from Japanese patients. Mariyama M, Kishi K, Nakamura K, Obata H, Nishimura S. Jpn J Cancer Res; 1989 Jul 01; 80(7):622-6. PubMed ID: 2507485 [Abstract] [Full Text] [Related]
15. Ki-ras gene mutations and absence of p53 gene mutations in spontaneous and urethane-induced early lung lesions in CBA/J mice. Cazorla M, Hernández L, Fernández PL, Fabra A, Peinado MA, Dasenbrock C, Tillmann T, Kamino K, Campo E, Kohler M, Morawieltz G, Cardesa A, Tomatis L, Mohr U. Mol Carcinog; 1998 Apr 01; 21(4):251-60. PubMed ID: 9585255 [Abstract] [Full Text] [Related]
16. High frequency of Ki-ras codon 12 mutations in pancreatic adenocarcinomas. Grünewald K, Lyons J, Fröhlich A, Feichtinger H, Weger RA, Schwab G, Janssen JW, Bartram CR. Int J Cancer; 1989 Jun 15; 43(6):1037-41. PubMed ID: 2659539 [Abstract] [Full Text] [Related]
17. Analysis of K-ras gene mutations in rare pancreatic and ampullary tumours. Ebert MP, Hoffmann J, Schneider-Stock R, Kasper HU, Schulz HU, Lippert H, Roessner A, Malfertheiner P. Eur J Gastroenterol Hepatol; 1998 Dec 15; 10(12):1025-9. PubMed ID: 9895049 [Abstract] [Full Text] [Related]
18. Aristolochic acid activates ras genes in rat tumors at deoxyadenosine residues. Schmeiser HH, Janssen JW, Lyons J, Scherf HR, Pfau W, Buchmann A, Bartram CR, Wiessler M. Cancer Res; 1990 Sep 01; 50(17):5464-9. PubMed ID: 2201437 [Abstract] [Full Text] [Related]
19. p53, Ki-ras, and DNA ploidy in human pancreatic ductal adenocarcinomas. Weyrer K, Feichtinger H, Haun M, Weiss G, Ofner D, Weger AR, Umlauft F, Grünewald K. Lab Invest; 1996 Jan 01; 74(1):279-89. PubMed ID: 8569192 [Abstract] [Full Text] [Related]
20. High yields of K-ras mutations in intraductal papillary mucinous tumors and invasive adenocarcinomas induced by N-nitroso(2-hydroxypropyl)(2-oxopropyl)amine in the pancreas of female Syrian hamsters. Sugio K, Gazdar AF, Albores-Saavedra J, Kokkinakis DM. Carcinogenesis; 1996 Feb 01; 17(2):303-9. PubMed ID: 8625455 [Abstract] [Full Text] [Related] Page: [Next] [New Search]